Ovamex, Injektionslösung in einer Fertigspritze
7680687920018
CH-68792
Injektionslösung
Associated product:
OVAMEX sol inj 0.25 mg/0.5ml ser pré
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ganirelixum
|
0.25 MG | Substance | Wirkstoff (Principe actif) |
|
ganirelixi acetas
|
- | Substance | WIZUS |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.023 MG | Substance | HBESI |
Authorization holder
Future Health Pharma GmbH
8620 Wetzikon ZH
Authorization information
- Swissmedic authorization number
- 68792
- Drug name
- Ovamex, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- H01CC01
- Authorization status
- Revoked/Withdrawn
- Dispensing category
- A
- First authorization
- 06/02/2023
- Authorization expiration date
- 01/08/2026
- IT Number
- 07.09.0.
- Domain
- Human medicine
Package details
- Description (FR)
- OVAMEX sol inj 0.25 mg/0.5ml ser pré
- Description (DE)
- OVAMEX Inj Lös 0.25 mg/0.5ml Fertspr
- Market launch
- 06/02/2023
- Market withdrawal
- 01/08/2026
- Narcotic (BTM)
- No
Other package sizes (1)
OVAMEX sol inj ser prérempl 5 pce
5 FESP
GTIN: 7680687920025